Log in to save to my catalogue

Complement activation products in tears of dry eye and meibomian gland dysfunction

Complement activation products in tears of dry eye and meibomian gland dysfunction

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7fd469cdb84741d7860052cbe7ce5d77

Complement activation products in tears of dry eye and meibomian gland dysfunction

About this item

Full title

Complement activation products in tears of dry eye and meibomian gland dysfunction

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2024-01, Vol.14 (1), p.43-43, Article 43

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Sixty-seven patients (38 woman; median age, 69 years) were enrolled to assess complement activation products (CAPs) in tear fluid with/without dry eye (DE) and with/without meibomian gland dysfunction (MGD). Patients were divided into four groups based on the presence/absence of DE and MGD: group DM had both DE and MGD, group DN had DE without MGD,...

Alternative Titles

Full title

Complement activation products in tears of dry eye and meibomian gland dysfunction

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_7fd469cdb84741d7860052cbe7ce5d77

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7fd469cdb84741d7860052cbe7ce5d77

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-023-46634-7

How to access this item